MDXG vs. NBIS

Last updated Aug 1, 2026

MDXG (MiMedx Group, Inc.) and NBIS (Nebius Group N.V.) are both stocks. MDXG operates in Medical Devices (Healthcare), while NBIS operates in Internet Content & Information (Communication Services). Over the past year, MDXG returned -42.32% vs 266.17% for NBIS. Their 0.07 correlation means their historical movements had little consistent relationship.

Performance

MDXG vs. NBIS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MiMedx Group, Inc. (MDXG) and Nebius Group N.V. (NBIS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MDXG achieves a -39.00% return, which is significantly lower than NBIS's 127.48% return.

MDXG

• 1D: -3.28%
• 1M: 4.56%
• 6M: -19.18%
• YTD: -39.00%
• 1Y: -42.32%
• 3Y*: -19.54%
• 5Y*: -19.56%
• 10Y*: -5.84%
• ALL TIME*: 14.68%

NBIS

• 1D: 1.05%
• 1M: -11.69%
• 6M: 123.51%
• YTD: 127.48%
• 1Y: 266.17%
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: 265.05%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
MDXG MiMedx Group, Inc.	$7.26M	$5.86M	$5.57M
NBIS Nebius Group N.V.	$4.73B	$4.16B	$4.21B

MDXG vs. NBIS - Yearly Performance Comparison

	2026 (YTD)	2025	2024
MDXG MiMedx Group, Inc.	-39.00%	-29.63%	65.01%
NBIS Nebius Group N.V.	127.48%	202.18%	46.25%

Correlation

The correlation between MDXG and NBIS is -0.05, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	-0.05
Correlation (All Time) Calculated using the full available price history since Oct 18, 2024	0.07

The correlation between MDXG and NBIS shifts across timeframes, from -0.05 (1 year) to 0.07 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap MDXG : $601.99M NBIS : $45.70B
EPS MDXG : $0.04 NBIS : $3.08
PE Ratio MDXG : 98.61 NBIS : 61.75
PEG Ratio MDXG : 0.02 NBIS : 21.22
PS Ratio MDXG : 1.73 NBIS : 58.84
PB Ratio MDXG : 2.83 NBIS : 8.12
Total Revenue (TTM) MDXG : $355.17M NBIS : $877.90M
Gross Profit (TTM) MDXG : $280.05M NBIS : $420.60M
EBITDA (TTM) MDXG : $22.16M NBIS : -$52.78M

Return for Risk

MDXG vs. NBIS — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

MDXG

MDXG Risk / Return Rank: 10
MDXG Sharpe Ratio Rank: 4
MDXG Sortino Ratio Rank: 6
MDXG Omega Ratio Rank: 7
MDXG Calmar Ratio Rank: 17
MDXG Martin Ratio Rank: 16

NBIS

NBIS Risk / Return Rank: 92
NBIS Sharpe Ratio Rank: 94
NBIS Sortino Ratio Rank: 92
NBIS Omega Ratio Rank: 88
NBIS Calmar Ratio Rank: 95
NBIS Martin Ratio Rank: 93

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

MDXG vs. NBIS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for MiMedx Group, Inc. (MDXG) and Nebius Group N.V. (NBIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	MDXG	NBIS	Difference
Sharpe ratio: Return per unit of total volatility	-1.06	2.22	-3.28
Sortino ratio: Return per unit of downside risk	-1.55	2.96	-4.51
Omega ratio: Gain probability vs. loss probability	0.82	1.34	-0.52
Calmar ratio: Return relative to maximum drawdown	-0.70	5.21	-5.91
Martin ratio: Return relative to average drawdown	-1.19	11.53	-12.71

MDXG vs. NBIS - Sharpe Ratio Comparison

The current MDXG Sharpe Ratio is -1.06, which is lower than the NBIS Sharpe Ratio of 2.22. The chart below compares the historical Sharpe Ratios of MDXG and NBIS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

MDXG vs. NBIS - Drawdown Comparison

The maximum MDXG drawdown since its inception was -93.83%, which is greater than NBIS's maximum drawdown of -58.27%. Use the drawdown chart below to compare losses from any high point for MDXG and NBIS.

Drawdown Indicators

	MDXG	NBIS	Difference
Max Drawdown Largest peak-to-trough decline	-93.83%	-58.27%	-35.56%
Max Drawdown (1Y) Largest decline over 1 year	-61.24%	-48.30%	-12.94%
Max Drawdown (3Y) Largest decline over 3 years	-68.36%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-83.39%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-93.60%	—	—
Current Drawdown Current decline from peak	-77.00%	-33.58%	-43.42%
Average Drawdown Average peak-to-trough decline	-53.70%	-19.18%	-34.52%
Ulcer Index Depth and duration of drawdowns from previous peaks	35.92%	21.79%	+14.13%

Volatility

MDXG vs. NBIS - Volatility Comparison

The current volatility for MiMedx Group, Inc. (MDXG) is 10.70%, while Nebius Group N.V. (NBIS) has a volatility of 45.48%. This indicates that MDXG experiences smaller price fluctuations and is considered to be less risky than NBIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MDXG	NBIS	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.70%	45.48%	-34.78%
Volatility (6M) Calculated over the trailing 6-month period	30.96%	83.51%	-52.55%
Volatility (1Y) Calculated over the trailing 1-year period	41.60%	113.57%	-71.97%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	61.44%	113.26%	-51.82%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	73.88%	113.26%	-39.38%

Dividends

MDXG vs. NBIS - Dividend Comparison

Neither MDXG nor NBIS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both MDXG and NBIS in my portfolio?

MDXG and NBIS have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MDXG or NBIS?

NBIS has higher volatility (45.48%) compared to MDXG (10.70%). In terms of maximum drawdown, MDXG dropped -93.83% vs NBIS's -58.27%.

Which has better risk-adjusted returns?

NBIS currently has the higher Sharpe Ratio (2.22 vs -1.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.